Beta-blockers before surgery linked to lower risk of heart-related events

Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events 30 days after surgery in patients with heart failure or a recent myocardial infarction (MI, heart attack), according to a study.